Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer

作者：Wu Xuan di; Song Yong Chun; Cao Pei Long; Zhang Hao; Guo Qi; Yan Rong; Diao Dong mei; Cheng Yao; Dang Cheng Xue^*

来源：Medical Oncology, 2014, 31(4): 894.

DOI：10.1007/s12032-014-0894-7

• Methylation
• miR-34a
• miR-34b/c
• Stool DNA
• CRC
• Biomarker

Explore potential screening biomarkers for noninvasive diagnosis of colorectal cancer (CRC) by testing methylation of the miR-34a and miR- 34b/c promoter in CRC patients' tissue and stool samples. Methylation- specific PCR analyses were performed on sample DNAs: 82 pairs of normal/ cancer samples, 82 CRC patients' stool samples, 40 healthy volunteer stool samples, and 20 healthy volunteer blood samples were recruited. miR-34a has been found methylated in 65 of 82 (79.3 %) the CRC tissue samples, but only 36 of 82 (43.9 %) in corresponding normal samples. And when testing miR- 34a in stool, 63 of 82 (76.8 %) CRC stool samples were observed methylated, and 2 of 40 (5 %) healthy samples were observed methylated. The methylation for miR- 34b/ c has been found in 80 of 82 (97.5 %) CRC tissue samples, 49 of 82 (59.8 %) corresponding CRC normal samples, and 74 of 79 (93.6 %) CRC stool samples. Yet we did not detect any methylation from healthy volunteers stool samples or healthy adult blood samples. Results indicated 76.8 % sensitivity and 93.6 % specificity of the miR- 34a methylation test for detecting CRC using stool samples. Meanwhile, the sensitivity and specificity of miR-34b/ c were 95 and 100 %, respectively. Moreover, our results revealed that abnormal DNA methylation of miR-34a was correlated with lymph metastasis (P = 0.010). Abnormal methylation of miR- 34a and miR- 34b/ c genes might be regarded as potential biomarkers for noninvasive screening and diagnosis of colorectal cancer.

• 出版日期2014-4
• 单位西安交通大学